Search Results1-8 of  8

  • TAKEKAWA KOJI ID: 9000003087513

    Japan Pharmaceutical Manufacturers Association (2002 from CiNii)

    Articles in CiNii:1

    • Questionnaire survey of in silico evaluation (physicochemical property, pharmacokinetics and toxicity)in pharmaceutical industries in Japan.(GENERAL SESSION BY ORAL PRESENTATION)(MINI SYMPOSIUM : STRATEGIC TOXICOKINETICS ON DRUG DISCOVERY(CURRENT SURVEY)) (2002)
  • TAKEKAWA Koji ID: 9000003830423

    Dept. of Ergonomics, Chiba University (1995 from CiNii)

    Articles in CiNii:1

    • Evaluation of Fatigue and Arousal Level during Driving : (1995)
  • TAKEKAWA Koji ID: 9000019132681

    Non-Clinical Evaluation Expert Committee, Drug Evaluation Committee, Japan Pharmaceutical Manufacturers Association (JPMA) (2012 from CiNii)

    Articles in CiNii:1

    • Perspectives on non-clinical safety evaluation of drug metabolites through the JSOT workshop (2012)
  • TAKEKAWA Koji ID: 9000283730700

    Mitsubishi Tanabe Pharma Corporation (2012 from CiNii)

    Articles in CiNii:1

    • Evaluation of phototoxic potential of lomefloxacin, sparfloxacin, and pirfenidone using long-evans rat –investigation of tissue distribution– (2012)
  • Takekawa Koji ID: 9000242882905

    Mitsubishi Tanabe Pharma Corporation (2013 from CiNii)

    Articles in CiNii:1

    • P-017 The in vivo DNA adductome analysis in rat liver (2nd report)(Poster presentation) (2013)
  • Takekawa Koji ID: 9000258576608

    Non-Clinical Evaluation Subcommittee, Drug Evaluation Committee, Japan Pharmaceutical Manufacturers Association (JPMA) (2010 from CiNii)

    Articles in CiNii:1

    • A QUESTIONNAIRE SURVEY ON NONCLINICAL SAFETY EVALUATION OF DRUG METABOLITES (2010)
  • Takekawa Koji ID: 9000317127180

    Mitsubishi Tanabe Pharma Corporation (2014 from CiNii)

    Articles in CiNii:1

    • O-7 Investigation for mechanism of DNA adduct formation by 2,4- and 2,6-diaminotoluene using DNA adductome analysis(Platform Session 2) (2014)
  • Takekawa Koji ID: 9000389552130

    Safety Research Laboratories, Sohyaku Innovative Research Division, Mitsubishi Tanabe Pharma Corporation (2018 from CiNii)

    Articles in CiNii:1

    • Comparison of Drug Metabolism and Its Related Hepatotoxic Effects in HepaRG, Cryopreserved Human Hepatocytes, and HepG2 Cell Cultures (2018)
Page Top